PR NEWS WIRE June 10, 2019
MANCHESTER, England, June 10, 2019 /PRNewswire/ -- An upsurge in demand for proton beam therapy was predicted today as the centenary of the discovery of the proton was celebrated at a major scientific conference.
Proton beam therapy, an innovative form of radiotherapy that delivers cancer treatment in a more targeted manner, has recently arrived in the UK through the Rutherford Cancer Centres and an NHS facility. As the number of patients treated with this precision therapy grows, there is a debate about the benefits that this innovative treatment can bring.
Recent estimates show that up to 20% of UK prostate cancer patients each year could be better treated with high energy proton beam therapy. Each year in the UK 47,000 men are diagnosed with prostate cancer.
A study released last month by the University of Pennsylvania revealed that the risk of side effects from toxicity to the body was two-thirds lower for proton beam therapy patients compared to conventional radiation therapies. Researchers leading the study also highlighted that overall survival rates were similar in both groups, indicating the reduced toxicity with proton beam therapy did not come at the cost of effectiveness.
Read the Full Article Here:
https://finance.yahoo.com/news/proton-partners-international-protons-play-110600071.html